Bioengineered chinese hamster ovary cells with golgi-targeted 3-O-sulfotransferase-1 biosynthesize heparan sulfate with an antithrombin-binding site

Payel Datta, Guoyun Li, Bo Yang, Xue Zhao, Jong Youn Baik, Trent R. Gemmill, Susan T. Sharfstein, Robert J. Linhardt

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

Background: CHO-S cells produce non-anticoagulant heparan sulfate (HS) even when transfected with HS3st1 and NDST2. Results: Golgi targeting of HS3st1 alone in bioengineered CHO-S cells afforded anticoagulant HS. Conclusion: Targeting of HS3st1 to the Golgi ensured its action in biosynthesis and modified the action of other biosynthetic enzymes. Significance: Engineering the production of HS and potentially heparin could provide a safer form of this important anticoagulant drug.

Original languageEnglish
Pages (from-to)37308-37318
Number of pages11
JournalJournal of Biological Chemistry
Volume288
Issue number52
DOIs
StatePublished - 27 Dec 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'Bioengineered chinese hamster ovary cells with golgi-targeted 3-O-sulfotransferase-1 biosynthesize heparan sulfate with an antithrombin-binding site'. Together they form a unique fingerprint.

Cite this